Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
5.
Int J STD AIDS ; 27(12): 1071-1078, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-26404110

RESUMEN

External genital warts, caused by human papillomavirus, have a significant clinical, epidemiological, and financial impact, including the risk for malignant transformation. Treatment modalities include: (a) destructive (ablative); (b) cytotoxic (proapoptotic) and (c) immunomodulatory, with success and recurrence rates varying from 23% to 94% and from 4.1% to 77%, respectively. Most studies evaluated only single modality therapy, with few reports examining a combined approach for external genital warts management. The introduction of sinecatechins ointment in recent years has resulted in very low recurrence rates of 4.1-10.6%, despite lower initial clearance rates than ablative methods. We present a retrospective review of 27 patients who underwent combined therapy for external genital warts by using one or two sessions of cryodestruction combined with 25% podophyllin as the cytotoxic agent, and post-ablation immunomodulation with topical sinecatechins 15% ointment. This approach resulted in an excellent initial clearance rate of 96.3% with a recurrence rate of 7.4% after a total period of six months of follow-up. We suggest the importance of the combined approach in external genital warts management including post-ablative immunomodulation to augment the immune response and combat the residual latent infection. We hope to encourage trials examining the combined approach to the treatment of external genital warts.


Asunto(s)
Antiinfecciosos Locales/administración & dosificación , Catequina/uso terapéutico , Condiloma Acuminado/tratamiento farmacológico , Criocirugía , Inmunomodulación , Papillomaviridae , Podofilino/administración & dosificación , Administración Cutánea , Adolescente , Adulto , Anciano , Antiinfecciosos Locales/uso terapéutico , Catequina/administración & dosificación , Catequina/efectos adversos , Terapia Combinada , Condiloma Acuminado/virología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pomadas , Extractos Vegetales/administración & dosificación , Estudios Retrospectivos , Resultado del Tratamiento , Adulto Joven
6.
Australas J Dermatol ; 57(1): e8-10, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25333656

RESUMEN

Cutaneous angiomyxomas are myofibroblastic neoplasms with locally aggressive behaviour and a high risk of recurrence. We describe a case of a solitary cutaneous angiomyxoma presenting on the nasal dorsum of a 28-year-old man, excised with Mohs surgery using permanent section control and repaired with an advancement flap. Histology showed myxoid nests of bland CD34-positive and vimentin-positive stellate and spindled cells in the deep dermis and abundant thin-walled blood vessels. An echocardiogram, performed to rule out the possibility of a cardiac myxoma with cutaneous embolisation, was normal.


Asunto(s)
Cirugía de Mohs , Mixoma/cirugía , Neoplasias Nasales/cirugía , Adulto , Humanos , Masculino , Mixoma/patología , Neoplasias Nasales/patología
7.
Dermatol Online J ; 21(8)2015 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-26437169

RESUMEN

Becker nevus (BN) is a common benign condition occurring most often in young men, much more often than in women. Acne isolated within a BN is a rare phenomenon hypothesized to occur, at least in part, due to increased androgen sensitivity within the nevus. We present a rare case of papular acne with in a BN of a 14 year-old girl.


Asunto(s)
Acné Vulgar/etiología , Andrógenos , Neoplasias Hormono-Dependientes/complicaciones , Nevo/complicaciones , Neoplasias Cutáneas/complicaciones , Acné Vulgar/tratamiento farmacológico , Administración Cutánea , Adolescente , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Peróxido de Benzoílo/administración & dosificación , Peróxido de Benzoílo/uso terapéutico , Eritromicina/administración & dosificación , Eritromicina/uso terapéutico , Femenino , Humanos , Neoplasias Hormono-Dependientes/patología , Nevo/patología , Glándulas Sebáceas/patología , Distribución por Sexo , Neoplasias Cutáneas/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA